Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

'Normal' is killing us.

Donald Trump is out of the White House. COVID-19 is fading, at least in wealthier nations. The world, they say, is returning to “normal.” That’s the narrative that the corporate media is selling. But there’s a problem: “normal” is destroying our planet, threatening our democracies, concentrating massive wealth in a tiny elite, and leaving billions of people without access to life-saving vaccines amid a deadly pandemic. Here at Common Dreams, we refuse to accept any of this as “normal.” Common Dreams just launched our Mid-Year Campaign to make sure we have the funding we need to keep the progressive, independent journalism of Common Dreams alive. Whatever you can afford—no amount is too large or too small—please donate today to support our nonprofit, people-powered journalism and help us meet our goal.

Please select a donation method:

In screenshot from the ad campaign ‘Time Is Precious,” funded by the nation's pharmaceutical lobby. (Image: Screenshot/YouTube)

How Big Pharma Is Trying to Improve Its Image

Jim Hightower

 by Creators.com

Big news, people! Especially for those of you upset by the skyrocketing prices of the essential prescription medicines you take — including thousands of patients who were hit last year with a 5,000 percent price increase for one lifesaving drug!

Determined to do something about those despised price hikes, drugmakers themselves have reached into their corporate toolbox for the two most effective means they have to fix their price problem. Of course, putting more corporate cash into research to produce new medicines would be one of those tools, and a renewed commitment to honest competition would be the other, right?

Right! But Big Pharma gave up years ago on doing right, turning to two other corporate tools that have reliably generated a gusher of profits for them: advertising and lobbying. So here they come, wielding bigger-than-ever ad-and-lobbying budgets to deal with that pesky matter of public anger at price gouging.

If you wonder why Congress keeps ignoring what the people want it to do — while doing things that people don't want it doing — take a peek at the unique PR campaign now being run by Pharmaceutical Research and Manufacturers of America. PhRMA is America's largest pharmaceutical lobbying group and represents Eli Lilly, Pfizer, GlaxoSmithKline, Merck & Co and about three dozen other drug manufactures.

The intent of PhRMA's multimillion-dollar PR blitz and intensified offensive in Congress is not to restrain the gouging but to improve the industry's image in hopes of restraining lawmakers from taking steps to rein in prescription costs. Of course, the ads dishonestly fail to mention the selfish intent of being allowed to keep ripping off patients, instead pitching drugmakers as selfless saviors of humanity. They feature soft scenes of drug researchers in white lab coats urgently trying to find new cures, scripted testimonials from patients and of course scenes of drugmakers altruistically aiding poor people.

The American public is dismayed and disgusted by the flagrant greed of drugmakers that are shamefully zooming the prices of medicines into the stratosphere, turning necessities into unaffordable luxuries. As a result, there is a growing demand for Congress to take action to stop the industry's out-of-control gouging.

Hoping to counter this demand for action, drug companies have launched their massive advertising campaign, not only running radio and print ads but also placing ads on Facebook, Twitter and other social media websites. Yet it's not likely that you've seen or heard any of them. That's because drug chieftains don't care what you and I think. Moreover, they know they couldn't possibly persuade us to let them keep jacking up our prices. So, their "public" relations effort has made the odd and seemingly counterproductive move of sidestepping the actual public, instead narrowly targeting a very tiny audience.

As one CEO arrogantly put it: "We've identified 7,000 Americans who matter," thus dismissing the other 330 million of us as nobodies. "We're focusing on those in policy positions ... to fight structural issues," he sniffed. By "structural issues," he means convincing Congress to take no action to reform the present pricing structure of monopolistic drugmakers, whose guiding corporate ethic is: "Bleed 'em for all they've got."

So this is a surreptitious PR campaign meant to reach only the eyes and ears of policy elites. The goal is to have Congress — once again — ignore what the people want it to do, thus allowing the corporate few "who matter" to keep fleecing the many. The word for this is "plutocracy." The industry is spending millions on this corporate medicine show not to protect its notorious profiteering but to protect you from public officials who might try to stop them from overcharging you. It's enough to make you sick.


© 2021 Creators Syndicate
Jim Hightower

Jim Hightower

Jim Hightower is a national radio commentator, writer, public speaker, and author of the books "Swim Against The Current: Even A Dead Fish Can Go With The Flow" (2008) and "There's Nothing in the Middle of the Road But Yellow Stripes and Dead Armadillos: A Work of Political Subversion" (1998). Hightower has spent three decades battling the Powers That Be on behalf of the Powers That Ought To Be - consumers, working families, environmentalists, small businesses, and just-plain-folks.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

'We Can't Turn Our Backs': 60+ Lawmakers Demand Biden Extend Pause on Student Loan Payments

"President Biden should cancel student debt, but in the meantime he should extend the payment pause so that borrowers aren't hurt."

Jake Johnson, staff writer ·


US and Israel Vote 'No' as 184 Nations Condemn American Blockade of Cuba

"The U.N. vote... on Cuba was a chance for President Biden to show global leadership," said CodePink co-founder Medea Benjamin. "He failed miserably."

Brett Wilkins, staff writer ·


With Planet's Future at Stake, Biden Told to Be Bold With Pick for Top Energy Post

"It's time to treat climate change like the emergency it is, and stop approving new fossil fuel extraction and infrastructure, reads a letter signed by over 300 climate-focused groups.

Jessica Corbett, staff writer ·


SCOTUS Solidifies Students' Free Speech Protections, Upholding Right to Say 'F**k Cheer'

"The message from this ruling is clear—free speech is for everyone, and that includes public school students."

Brett Wilkins, staff writer ·


Right-Wing SCOTUS Majority Rules Union Organizing on Farms Violates Landowners' Rights

The Supreme Court "fails to balance a farmer's property rights with a farm worker's human rights," said United Farm Workers of America.

Kenny Stancil, staff writer ·